Heat-inducible amplifier vector for high-level expression of granulocyte-macrophage colony-stimulating factor

References

• Tagawa M. Cytokine therapy for cancer. Curr Pharm Des 2000; 6: 681–699
   PubMed Web of Science ®Google Scholar
• Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev 2002; 188: 147–154
   PubMed Web of Science ®Google Scholar
• Ravaud A, Delaunay M, Chevreau C, Coulon V, Debled M, Bret-Dibat C, Courbon F, Gualde N, Nguyen Bui B. Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: A randomized phase II trial. Br J Cancer 2001; 85: 1467–1471
   PubMed Web of Science ®Google Scholar
• Hast R, Hellstrom-Lindberg E, Ohm L, Bjorkholm M, Celsing F, Dahl IM, Dybedal I, Gahrton G, Lindberg G, Lerner R, Linder O, Lofvenberg E, Nilsson-Ehle H, Paul C, Samuelsson J, Tangen JM, Tidefelt U, Turesson I, Wahlin A, Wallvik J, Winquist I, Oberg G, Bernell P. No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: Better outcome in patients with less proliferative disease. Leukemia 2003; 17: 1827–1833
   PubMed Web of Science ®Google Scholar
• De Giovanni C, Nanni P, Forni G. The prospects for cancer gene therapy. Int J Immunopharmacol 2000; 22: 1025–1032
   PubMed Web of Science ®Google Scholar
• Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF. Cancer Gene Ther 1999; 6: 81–88
   PubMed Web of Science ®Google Scholar
• Ju DW, Cao X, Acres B. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model. Cancer Gene Ther 1997; 4: 139–144
   PubMed Web of Science ®Google Scholar
• Schatzlein AG. Non-viral vectors in cancer gene therapy: Principles and progress. Anticancer Drugs 2001; 12: 275–304
   PubMed Web of Science ®Google Scholar
• Buchsel PC, Forgey A, Grape FB, Hamann SS. Granulocyte macrophage colony-stimulating factor: Current practice and novel approaches. Clin J Oncol Nurs 2002; 6: 198–205
   PubMedGoogle Scholar
• Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS, Ansel JC. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 1996; 56: 2191–2198
   PubMed Web of Science ®Google Scholar
• Chatterjee SK, Qin H, Manna S, Tripathi PK. Recombinant vaccinia virus expressing cytokine GM-CSF as tumor vaccine. Anticancer Res 1999; 19: 2869–2873
   PubMed Web of Science ®Google Scholar
• Couch M, Saunders JK, O'Malley BW, Jr, Pardoll D, Jaffee E. Genetically engineered tumor cell vaccine in a head and neck cancer model. Laryngoscope 2003; 113: 552–556
   PubMed Web of Science ®Google Scholar
• Salgia R, Lynch T, Skarin A, Lucca J, Lynch C, Jung K, Hodi FS, Jaklitsch M, Mentzer S, Swanson S, Lukanich J, Bueno R, Wain J, Mathisen D, Wright C, Fidias P, Donahue D, Clift S, Hardy S, Neuberg D, Mulligan R, Webb I, Sugarbaker D, Mihm M, Dranoff G. Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol 2003; 21: 624–630
   PubMed Web of Science ®Google Scholar
• Toda M, Martuza RL, Rabkin SD. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor. Mol Ther 2000; 2: 324–329
   PubMed Web of Science ®Google Scholar
• Marshall E. Gene therapy's growing pains. Science 1995; 269: 1050, 1052–1055
   PubMed Web of Science ®Google Scholar
• Mahvi DM, Shi FS, Yang NS, Weber S, Hank J, Albertini M, Schiller J, Schalch H, Larson M, Pharo L, Gan J, Heisey D, Warner T, Sondel PM. Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: Report of a phase I/IB study. Hum Gene Ther 2002; 13: 1711–1721
   PubMed Web of Science ®Google Scholar
• Armstrong TD, Jaffee EM. Cytokine modified tumor vaccines. Surg Oncol Clin N Am 2002; 11: 681–696
   PubMedGoogle Scholar
• Bohlius J, Reiser M, Schwarzer G, Engert A. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: A systematic review. Br J Haematol 2003; 122: 413–423
   PubMed Web of Science ®Google Scholar
• Thomas X, Boiron JM, Huguet F, Reman O, Sutton L, Turlure P, Garban F, Gardin C, Espinouse D, Boulat O, Lheritier V, Fiere D. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: A multicenter randomized study. Hematol J 2004; 5: 384–394
   PubMedGoogle Scholar
• Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemother Pharmacol 2000; 46(Suppl)S67–S72
   PubMed Web of Science ®Google Scholar
• Nemunaitis J, Sterman D, Jablons D, Smith JW, 2nd, Fox B, Maples P, Hamilton S, Borellini F, Lin A, Morali S, Hege K. Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer. J Natl Cancer Inst 2004; 96: 326–331
   PubMed Web of Science ®Google Scholar
• Dillman R, Selvan S, Schiltz P, Peterson C, Allen K, Depriest C, McClay E, Barth N, Sheehy P, de Leon C, Beutel L. Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: Planned interim analysis. Cancer Biother Radiopharm 2004; 19: 658–665
   PubMed Web of Science ®Google Scholar
• Soiffer R, Hodi FS, Haluska F, Jung K, Gillessen S, Singer S, Tanabe K, Duda R, Mentzer S, Jaklitsch M, Bueno R, Clift S, Hardy S, Neuberg D, Mulligan R, Webb I, Mihm M, Dranoff G. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. J Clin Oncol 2003; 21: 3343–3350
   PubMed Web of Science ®Google Scholar
• Yew NS, Wysokenski DM, Wang KX, Ziegler RJ, Marshall J, McNeilly D, Cherry M, Osburn W, Cheng SH. Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum Gene Ther 1997; 8: 575–584
   PubMed Web of Science ®Google Scholar
• Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985; 41: 521–530
   PubMed Web of Science ®Google Scholar
• Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J, Marquet M, Hobart P, Norman J, Manthorpe M. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996; 7: 1205–1217
   PubMed Web of Science ®Google Scholar
• Doll RF, Crandall JE, Dyer CA, Aucoin JM, Smith FI. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Ther 1996; 3: 437–447
   PubMed Web of Science ®Google Scholar
• Tsang TC, Brailey JL, Vasanwala FH, Wu RS, Liu F, Clark PR, Meade-Tollin L, Luznick L, Stopeck AT, Akporiaye ET, Harris DT. Construction of new amplifier expression vectors for high levels of IL-2 gene expression. Int J Mol Med 2000; 5: 295–300
   PubMed Web of Science ®Google Scholar
• Schiller P, Amin J, Ananthan J, Brown ME, Scott WA, Voellmy R. Cis-acting elements involved in the regulated expression of a human HSP70 gene. J Mol Biol 1988; 203: 97–105
   PubMed Web of Science ®Google Scholar
• Morimoto RI, Kline MP, Bimston DN, Cotto JJ. The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 1997; 32: 17–29
   PubMed Web of Science ®Google Scholar
• Edwards MJ. Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links? Cell Stress Chaperones 1998; 3: 213–220
   PubMed Web of Science ®Google Scholar
• Vasanwala F, Tsang T, Fellah A, Yorgin P, Harris D. A novel expression vector induced by heat, gamma-radiation and chemotherapy. Gene Ther Mol Biol 2000; 5: 1–7
   Google Scholar
• Tsang TC, Harris DT, Akporiaye ET, Chu RS, Brailey J, Liu F, Vasanwala FH, Schluter SF, Hersh EM. Mammalian expression vector with two multiple cloning sites for expression of two foreign genes. Biotechniques 1997; 22: 68
   PubMed Web of Science ®Google Scholar
• Arya SK, Guo C, Josephs SF, Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985; 229: 69–73
   PubMed Web of Science ®Google Scholar
• Tsang TC, Harris DT, Akporiaye ET, Schluter SF, Bowden GT, Hersh EM. Simple method for adapting DNA fragments and PCR products to all of the commonly used restriction sites. Biotechniques 1996; 20: 51–52
   PubMed Web of Science ®Google Scholar
• Xu J, Luznik L, Wong-Staal F, Gill GN. Hormone receptor regulation of the human immunodeficiency virus type 1 and type 2 long terminal repeats. J Biomed Sci 1996; 3: 323–331
   PubMedGoogle Scholar
• Zhang T, Tsang TC, Harris DT. Comparison of cis and trans tat gene expression in HIV LTR-based amplifier vectors. Biotechniques 2002; 33: 1146–1151
   PubMed Web of Science ®Google Scholar
• Gerner EW, Hersh EM, Pennington M, Tsang TC, Harris D, Vasanwala F, Brailey J. Heat-inducible vectors for use in gene therapy. Int J Hyperthermia 2000; 16: 171–181
   PubMed Web of Science ®Google Scholar
• Borrelli MJ, Schoenherr DM, Wong A, Bernock LJ, Corry PM. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res 2001; 61: 1113–1121
   PubMed Web of Science ®Google Scholar
• Andrews JM, Newbound GC, Lairmore MD. Transcriptional modulation of viral reporter gene constructs following induction of the cellular stress response. Nucleic Acids Res 1997; 25: 1082–1084
   PubMed Web of Science ®Google Scholar
• Kaul G, Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: In vitro and in vivo studies. Pharm Res 2005; 22: 951–961
   PubMed Web of Science ®Google Scholar
• Wolschek MF, Thallinger C, Kursa M, Rossler V, Allen M, Lichtenberger C, Kircheis R, Lucas T, Willheim M, Reinisch W, Gangl A, Wagner E, Jansen B. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 2002; 36: 1106–1114
   PubMed Web of Science ®Google Scholar
• Oshima Y, Sakamoto T, Yamanaka I, Nishi T, Ishibashi T, Inomata H. Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther 1998; 5: 1347–1354
   PubMed Web of Science ®Google Scholar